Psychosocial Interventions for Attention Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis by the CADDRA Guidelines Work GROUP.

ADHD caregiver interventions mind–body intervention physical exercise psychological interventions psychosocial treatment school-based interventions

Journal

Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646

Informations de publication

Date de publication:
01 Aug 2022
Historique:
received: 16 06 2022
revised: 25 07 2022
accepted: 29 07 2022
entrez: 26 8 2022
pubmed: 27 8 2022
medline: 27 8 2022
Statut: epublish

Résumé

Multiple psychosocial interventions to treat ADHD symptoms have been developed and empirically tested. However, no clear recommendations exist regarding the utilization of these interventions for treating core ADHD symptoms across different populations. The objective of this systematic review and meta-analysis by the CADDRA Guidelines work Group was to generate such recommendations, using recent evidence. Randomized controlled trials (RCT) and meta-analyses (MA) from 2010 to 13 February 2020 were searched in PubMed, PsycINFO, EMBASE, EBM Reviews and CINAHL. Studies of populations with significant levels of comorbidities were excluded. Thirty-one studies were included in the qualitative synthesis (22 RCT, 9 MA) and 24 studies (19 RCT, 5 MA) were included in the quantitative synthesis. Using three-level meta-analyses to pool results of multiple observations from each RCT, as well as four-level meta-analyses to pool results from multiples outcomes and multiple studies of each MA, we generated recommendations using the GRADE approach for: Cognitive Behavioral Therapy; Physical Exercise and Mind-Body intervention; Caregiver intervention; School-based and Executive intervention; and other interventions for core ADHD symptoms across Preschooler, Child, Adolescent and Adult populations. The evidence supports a recommendation for Cognitive Behavioral Therapy for adults and Caregiver intervention for Children, but not for preschoolers. There were not enough data to provide recommendations for the other types of psychosocial interventions. Our results are in line with previous meta-analytic assessments; however, they provide a more in-depth assessment of the effect of psychosocial intervention on core ADHD symptoms.

Identifiants

pubmed: 36009086
pii: brainsci12081023
doi: 10.3390/brainsci12081023
pmc: PMC9406006
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

J Pediatr Psychol. 2007 Jul;32(6):631-42
pubmed: 17556405
J Adolesc Health. 2016 Jun;58(6):652-8
pubmed: 27009741
J Dev Behav Pediatr. 2003 Jun;24(3):155-62
pubmed: 12806227
PLoS One. 2018 Nov 29;13(11):e0207905
pubmed: 30496240
J Am Acad Child Adolesc Psychiatry. 2018 Aug;57(8):593-602
pubmed: 30071980
Transl Pediatr. 2020 Feb;9(Suppl 1):S114-S124
pubmed: 32206589
J Atten Disord. 2019 Mar;23(5):423-434
pubmed: 27179355
J Crit Care. 2005 Jun;20(2):187-91; discussion 191-3
pubmed: 16139163
J Consult Clin Psychol. 2014 Dec;82(6):1115-1127
pubmed: 24865871
Psychol Med. 2020 Apr;50(6):894-919
pubmed: 32216846
JAMA Psychiatry. 2017 Aug 1;74(8):815-822
pubmed: 28658471
Behav Res Methods. 2013 Jun;45(2):576-94
pubmed: 23055166
Curr Psychiatry Rep. 2011 Oct;13(5):333-44
pubmed: 21779823
J Am Acad Child Adolesc Psychiatry. 2014 Jul;53(7):736-44
pubmed: 24954823
J Am Acad Child Adolesc Psychiatry. 2019 Apr;58(4):443-452
pubmed: 30768385
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
J Atten Disord. 2019 Feb;23(3):257-269
pubmed: 26362259
Neuropsychiatr Dis Treat. 2015 Oct 20;11:2721-35
pubmed: 26604761
Int J Qual Stud Health Well-being. 2017 Jun;12(sup1):1298267
pubmed: 28532329
J Clin Child Adolesc Psychol. 2018 Mar-Apr;47(2):213-235
pubmed: 28128989
J Interpers Violence. 2015 Mar;30(5):782-95
pubmed: 24920001
Neurosci Biobehav Rev. 2016 Sep;68:838-847
pubmed: 27450582
J Atten Disord. 2018 Feb;22(4):388-399
pubmed: 28038496
Res Dev Disabil. 2018 Jan;72:96-105
pubmed: 29121517
Pediatrics. 2015 Jan;135(1):40-8
pubmed: 25511122
PLoS One. 2017 Mar 15;12(3):e0173762
pubmed: 28296941
BMC Med Res Methodol. 2011 Apr 07;11:41
pubmed: 21473747
J Atten Disord. 2015 Feb;19(2):118-24
pubmed: 24071773
Neurosci Biobehav Rev. 2021 Sep;128:789-818
pubmed: 33549739
Am J Psychiatry. 2019 Jul 1;176(7):531-542
pubmed: 31014101
Lancet Psychiatry. 2017 Apr;4(4):310-319
pubmed: 28219628
J Child Psychol Psychiatry. 2014 May;55(5):436-45
pubmed: 24274762
Clin Psychol Rev. 2017 Mar;52:108-123
pubmed: 28088557
J Abnorm Psychol. 2012 Nov;121(4):991-1010
pubmed: 22612200
Biol Psychiatry. 2016 Dec 15;80(12):916-922
pubmed: 27086545
J Child Psychol Psychiatry. 2014 Aug;55(8):878-85
pubmed: 25158998
Arch Clin Neuropsychol. 2018 Mar 01;33(2):143-157
pubmed: 29106438
Nat Genet. 2019 Jan;51(1):63-75
pubmed: 30478444
J Evid Based Med. 2013 Feb;6(1):50-54
pubmed: 23557528
Atten Defic Hyperact Disord. 2018 Sep;10(3):223-235
pubmed: 29492784
Res Dev Disabil. 2016 Apr-May;51-52:160-72
pubmed: 26829402
J Dev Behav Pediatr. 2012 May;33(4):336-42
pubmed: 22371012
Psychol Bull. 1987 Mar;101(2):213-32
pubmed: 3562706
Brief Bioinform. 2020 Mar 23;21(2):553-565
pubmed: 30895308
J Abnorm Child Psychol. 2007 Aug;35(4):536-42
pubmed: 17333362
Transl Pediatr. 2018 Jan;7(1):36-47
pubmed: 29441281
Aust N Z J Psychiatry. 2012 Oct;46(10):958-65
pubmed: 22689334
J Am Acad Child Adolesc Psychiatry. 2018 Apr;57(4):231-232
pubmed: 29588047
Annu Rev Clin Psychol. 2010;6:155-79
pubmed: 17716032
Int J Sports Med. 2011 Dec;32(12):953-9
pubmed: 22068930
JAMA Psychiatry. 2016 Aug 1;73(8):815-825
pubmed: 27276220
J Psychiatr Res. 2011 Mar;45(3):295-301
pubmed: 20638079
Psychol Med. 2006 Feb;36(2):159-65
pubmed: 16420712
J Sch Health. 2003 Mar;73(3):127-8
pubmed: 12677731
J Abnorm Child Psychol. 2020 May;48(5):679-691
pubmed: 31938952
Behav Ther. 2011 Sep;42(3):462-74
pubmed: 21658528
BMC Psychiatry. 2020 Mar 12;20(1):120
pubmed: 32164655
Acta Psychiatr Scand. 2018 Feb;137(2):125-137
pubmed: 29282731
JAMA. 2010 Aug 25;304(8):875-80
pubmed: 20736471
J Abnorm Child Psychol. 2017 Jul;45(5):841-855
pubmed: 27628742
Am Psychol. 2015 Oct;70(7):581-92
pubmed: 26436310
Clin Neurophysiol. 2014 Jul;125(7):1407-16
pubmed: 24374088
Am J Psychiatry. 2020 Sep 1;177(9):834-843
pubmed: 32539527
Neuropsychol Rev. 2019 Dec;29(4):387-396
pubmed: 31446547
J Am Acad Child Adolesc Psychiatry. 2008 Sep;47(9):994-1009
pubmed: 18580502
J Atten Disord. 2021 Jul;25(9):1199-1206
pubmed: 31971056
Atten Defic Hyperact Disord. 2017 Mar;9(1):47-65
pubmed: 27866355
JAMA Psychiatry. 2014 Mar;71(3):319-25
pubmed: 24477798
J Am Acad Child Adolesc Psychiatry. 1993 Mar;32(2):315-7
pubmed: 8444759
Ann Fam Med. 2004 Nov-Dec;2(6):576-82
pubmed: 15576544
J Clin Psychiatry. 2020 Mar 24;81(3):
pubmed: 32237294
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
J Consult Clin Psychol. 2017 Mar;85(3):250-261
pubmed: 28221060
J Atten Disord. 2020 Sep;24(11):1605-1615
pubmed: 27261499
World Psychiatry. 2020 Jun;19(2):214-232
pubmed: 32394557
Iran J Med Sci. 2018 Nov;43(6):596-604
pubmed: 30510336
Psychol Med. 2015 Jan;45(2):361-73
pubmed: 25066615
Mol Psychiatry. 2019 Apr;24(4):562-575
pubmed: 29892054
Br J Psychiatry. 2020 Jul 14;:1-9
pubmed: 32662370
Child Care Health Dev. 2015 Nov;41(6):779-88
pubmed: 25988743
Lancet Psychiatry. 2018 Sep;5(9):727-738
pubmed: 30097390
Nat Hum Behav. 2017 Jan 10;1:0021
pubmed: 33954258
Medicine (Baltimore). 2019 Nov;98(46):e17980
pubmed: 31725664
Eur Child Adolesc Psychiatry. 2018 Jun;27(6):797-809
pubmed: 29086103
J Child Adolesc Psychopharmacol. 2013 Apr;23(3):163-78
pubmed: 23560602
BMJ. 2014 Jun 18;348:g3769
pubmed: 24942388
J Am Acad Child Adolesc Psychiatry. 2014 Feb;53(2):174-87
pubmed: 24472252
BMJ. 2004 Jun 19;328(7454):1490
pubmed: 15205295
Ital J Pediatr. 2010 Dec 22;36(1):79
pubmed: 21176172
Behav Ther. 2013 Jun;44(2):302-16
pubmed: 23611079
Neuropsychiatr Dis Treat. 2015 Nov 25;11:2943-52
pubmed: 26648726
JAMA Psychiatry. 2017 Jun 1;74(6):597-603
pubmed: 28492937
Arch Clin Neuropsychol. 2005 Aug;20(6):727-44
pubmed: 15953706
Am J Psychiatry. 2012 Oct;169(10):1038-55
pubmed: 22983386
World J Clin Cases. 2019 Sep 6;7(17):2420-2426
pubmed: 31559278
Front Psychiatry. 2018 Nov 16;9:571
pubmed: 30505283
J Atten Disord. 2018 Jun;22(8):806-812
pubmed: 27013028
J Am Acad Child Adolesc Psychiatry. 2019 Apr;58(4):423-432
pubmed: 30768391
AoB Plants. 2015 Oct 20;7:
pubmed: 26487676
J Atten Disord. 2014 May;18(4):275-82
pubmed: 22647288
Psychiatr Clin North Am. 2010 Mar;33(1):159-80
pubmed: 20159345
Front Hum Neurosci. 2018 Mar 29;12:100
pubmed: 29651240
BMC Psychiatry. 2011 Jul 25;11:116
pubmed: 21787431
J Atten Disord. 2017 Apr;21(6):508-521
pubmed: 24970720
Nat Rev Dis Primers. 2015 Aug 06;1:15020
pubmed: 27189265
PLoS One. 2016 Feb 17;11(2):e0148841
pubmed: 26886218
Pharmacoepidemiol Drug Saf. 2016 Jan;25(1):45-53
pubmed: 26549311
J Child Adolesc Psychopharmacol. 2015 Oct;25(8):611-7
pubmed: 26402485
JAMA Pediatr. 2017 Jul 3;171(7):e170691
pubmed: 28459927
Prev Chronic Dis. 2006 Apr;3(2):A52
pubmed: 16539793
J Child Psychol Psychiatry. 2015 Jun;56(6):618-31
pubmed: 25318650
J Psychopathol Behav Assess. 2021 Dec;43(4):778-792
pubmed: 35185276
Am J Psychiatry. 2010 Aug;167(8):958-68
pubmed: 20231319
Indian J Pediatr. 2008 Mar;75(3):223-8
pubmed: 18376088
J Atten Disord. 2020 Dec;24(14):1966-1976
pubmed: 28971722
Healthcare (Basel). 2017 Nov 18;5(4):
pubmed: 29156540
Iran J Psychiatry. 2014 Apr;9(2):47-54
pubmed: 25632280
Neuropsychology. 2019 Mar;33(3):425-444
pubmed: 30688493
J Child Psychol Psychiatry. 2020 Feb;61(2):140-147
pubmed: 31625605
Br J Psychiatry. 2016 Mar;208(3):210-2
pubmed: 26932481
J Child Psychol Psychiatry. 2013 Oct;54(10):1038-46
pubmed: 24007415
Cochrane Database Syst Rev. 2011 Jun 15;(6):CD007813
pubmed: 21678370

Auteurs

Valerie Tourjman (V)

Department of Psychiatry, Université de Montréal, Montreal, QC H3T 1J4, Canada.

Gill Louis-Nascan (G)

Department of Psychiatry, Université de Montréal, Montreal, QC H3T 1J4, Canada.
Department of Psychology, Université du Québec à Montréal, Montreal, QC H2X 3P2, Canada.

Ghalib Ahmed (G)

Departments of Family Medicine and Psychiatry, University of Alberta, Edmonton, AB T6G 2R3, Canada.

Anaïs DuBow (A)

Department of Psychiatry, Université de Montréal, Montreal, QC H3T 1J4, Canada.

Hubert Côté (H)

Department of Psychiatry, Université de Montréal, Montreal, QC H3T 1J4, Canada.

Nadia Daly (N)

Department of Psychiatry, Harvard University, Boston, MA 02115, USA.
Boston Children's Hospital, Harvard University, Boston, MA 02115, USA.

George Daoud (G)

Department of Psychiatry, Université de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada.

Stacey Espinet (S)

CADDRA-Canadian ADHD Resource Alliance, Toronto, ON M5A 3X9, Canada.

Joan Flood (J)

Department of Psychiatry, The Shoniker Clinic, Scarborough, ON M1E 4B9, Canada.

Emilie Gagnier-Marandola (E)

Department of Family Medicine, McGill University, Montreal, QC H3A 0G4, Canada.

Martin Gignac (M)

Child and Adolescent Psychiatry Division, McGill University, Montreal, QC H3A 0G4, Canada.

Gemma Graziosi (G)

Department of Psychology, York University, Toronto, ON M3J 1P3, Canada.

Zeeshan Mansuri (Z)

Boston Children's Hospital, Harvard University, Boston, MA 02115, USA.

Joseph Sadek (J)

Department of Psychiatry, Dalhousie University, Halifax, NS B3H 4R2, Canada.

Classifications MeSH